Interleukin-23 promotes the epithelial-mesenchymal transition of oesophageal carcinoma cells via the Wnt/β-catenin pathway

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Chen, Deyu ^a   Li, Wei ^a   Liu, Shenzha ^a   Su, Yuting ^a   Han, Guohu ^a   Xu, Chenchen ^a   Liu, Hongli ^a   Zheng, Tingting ^a   Zhou, Yuepeng ^a   Mao, Chaoming ^a  

^a JIANGSU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 23;

ANIMAL; CANCER TRANSPLANTATION; CELL MOTION; COCULTURE; EPITHELIAL MESENCHYMAL TRANSITION; ESOPHAGUS TUMOR; FEMALE; HUMAN; LYMPH NODE METASTASIS; MALE; METABOLISM; MIDDLE AGED; NUDE MOUSE; PATHOLOGY; PHYSIOLOGY; SECONDARY; SQUAMOUS CELL CARCINOMA; TUMOR CELL CULTURE; TUMOR CELL LINE; WNT SIGNALING PATHWAY;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL MOVEMENT; COCULTURE TECHNIQUES; EPITHELIAL-MESENCHYMAL TRANSITION; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; INTERLEUKIN-23; LYMPHATIC METASTASIS; MALE; MICE, NUDE; MIDDLE AGED; NEOPLASM TRANSPLANTATION; TUMOR CELLS, CULTURED; WNT SIGNALING PATHWAY;

EID: 84923774807     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep08604     Document Type: Article

References (38)

1. Jemal, A., Center, M. M., DeSantis, C. & Ward, E. M. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidem Biomar. 19, 1893-1907 (2010).
2. Chen, W. et al. Esophageal cancer incidence and mortality in China, 2009. J Thorac Dis. 5, 19-26 (2013).
3. Schneider, B J. & Urba, S. G. Preoperative chemoradiation for the treatment of locoregional esophageal cancer: the standard of care? Semin Radiat Oncol. 17, 45-52 (2007).
4. Thompson, S. K. et al. Improving the accuracy of TNM staging in esophageal cancer: a pathological review of resected specimens. Ann Surg Oncol. 15, 3447-3458 (2008).
5. Christiansen, J. J. & Rajasekaran, A. K. Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Res. 66, 8319-8326 (2006).
6. Ferrari-Amorotti, G. et al. Inhibiting interactions of lysine demethylase LSD1with snail/slug blocks cancer cell invasion. Cancer Res. 73, 235-245 (2013).
7. Cong, N. et al. Downregulated microRNA-200a promotes EMT and tumor growth through the wnt/beta-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma. Oncol Rep. 29, 1579-1587 (2013).
8. Aydogdu, E. et al. MicroRNA-regulated gene networks during mammary cell differentiation are associated with breast cancer. Carcinogenesis 33, 1502-1511 (2012).
9. Pacurari, M. et al. The microRNA-200 family targets multiple non-small cell lung cancer prognostic markers in H1299 cells and BEAS-2B cells. Int J Oncol. 43, 548-560 (2013).
10. Su, J. et al. MicroRNA-200a suppresses the Wnt/beta-catenin signaling pathway by interacting with beta-catenin. Int J Oncol. 40, 1162-1170 (2012).
11. Jorda, M. et al.Upregulation of MMP-9 inMDCKepithelial cell line in response to expression of the Snail transcription factor. J Cell Sci. 118, 3371-3385 (2005).
12. Gong, T. et al. Nuclear expression of Twist promotes lymphatic metastasis in esophageal squamous cell carcinoma. Cancer Biol Ther. 13, 606-613 (2012).
13. Yu, H., Kortylewski, M. & Pardoll, D. Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment. Nat Rev Immunol. 7, 41-51 (2007).
14. Schreiber, R. D., Old, L. J. & Smyth, M. J. Cancer immunoediting: integrating immunitys roles in cancer suppression and promotion. Science 331, 1565-1570 (2011).
15. Chen, D. et al. Chemokine/chemokine receptor interactions contribute to the accumulation of Th17 cells in patients with esophageal squamous cell carcinoma. Hum Immunol. 73, 1068-1072 (2012).
16. Volpe, E. et al. A critical function for transforming growth factor-beta, interleukin 23 and proinflammatory cytokines in driving and modulating human T(H)-17 responses. Nat Immnunol. 9, 650-657 (2008).
17. Kim, H. R. et al. Up-regulation of IL-23p19 expression in rheumatoid arthritis synovial fibroblasts by IL-17 through PI3-kinase-, NF-kappaB-And p38 MAPKdependent signalling pathways. Rheumatology 46, 57-64 (2007).
18. Nair, R. P. et al. Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat Genet. 41, 199-204 (2009).
19. Di Cesare, A., Di Meglio, P. & Nestle, F. O. The IL-23/Th17 axis in the immunopathogenesis of psoriasis. J Invest Dermatol. 129, 1339-1350 (2009).
20. Ugai, S. et al. Transduction of the IL-21 and IL-23 genes in human pancreatic carcinoma cells produces natural killer cell-dependent and-independent antitumor effects. Cancer Gene Ther. 10, 771-778 (2003).
21. Wang, Y. Q. et al. Induction of systemic immunity by expression of interleukin-23 in murine colon carcinoma cells. Int J Cancer 105, 820-824 (2003).
22. Shan, B., Yu, L., Shimozato, O., Li, Q. & Taqawa, M. Expression of interleukin-21 and-23 in human esophageal tumors produced antitumor effects in nude mice. Anticancer Res. 24, 79-82 (2004).
23. Cocco, C. et al. Complementary IL-23 and IL-27 anti-Tumor activities cause strong inhibition of human follicular and diffuse large B-cell lymphoma growth in vivo. Leukemia 26, 1365-1374 (2012).
24. Langowski, J. L. et al. IL-23 promotes tumour incidence and growth. Nature 442, 461-465 (2006).
25. Fukuda, M., Ehara, M., Suzuki, S., Ohmori, Y. & Sakashita, H. IL-23 promotes growth and proliferation in human squamous cell carcinoma of the oral cavity. Int J Oncol. 36, 1355-1365 (2010).
26. Li, J. et al. Interleukin 23 promotes hepatocellular carcinoma metastasis via NFkappa B induced matrix metalloproteinase 9 expression. PLoS One 7, e46264 (2012).
27. Li, J. et al. Interleukin 23 regulates proliferation of lung cancer cells in a concentration-dependent way in association with the interleukin-23 receptor. Carcinogenesis 34, 658-666 (2013).
28. Zhang, L. et al. IL-23 selectively promotes the metastasis of colorectal carcinoma cells with impaired Socs3 expression via the STAT5 pathway. Carcinogenesis 35, 1330-1340 (2014).
29. Yook, J. I. et al.AWnt-Axin2-GSK3 beta cascade regulates Snail1 activity in breast cancer cells. Nat Cell Biol. 8, 1398-1406 (2006).
30. MacDonald, B. T., Tamai, K. & He, X. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell 17, 9-26 (2009).
31. Wang, X. H. et al. Beta-catenin siRNA regulation of apoptosis-And angiogenesisrelated gene expression in hepatocellular carcinoma cells: potential uses for gene therapy. Oncol Rep. 24, 1093-1099 (2010).
32. Iwai, S. et al. Involvement of the Wnt-beta-catenin pathway in invasion and migration of oral squamous carcinoma cells. Int J Oncol. 37, 1095-1103 (2010).
33. Zheng, H. X. et al. Glycogen synthase kinase-3 beta regulates Snail and betacatenin expression during Fas-induced epithelial-mesenchymal transition in gastrointestinal cancer. Eur J Cancer 49, 2734-2746 (2013).
34. Kao, S. H. et al. GSK3 beta controls epithelial-mesenchymal transition and tumor metastasis by CHIP-mediated degradation of Slug. Oncogene 33, 3172-3182 (2014).
35. Zhou, B. et al. Interactions Between beta-Catenin and Transforming Growth Factor-beta Signaling Pathways Mediate Epithelial-Mesenchymal Transition and Are Dependent on the Transcriptional Co-Activator cAMP-response Elementbinding Protein (CREB)-binding Protein (CBP). J Biol Chem. 287, 7026-7038 (2012).
36. Ni, B., Chen, S., Xie, H. & Ma, H. Functional polymorphisms in interleukin-23 receptor and susceptibility to esophageal squamous cell carcinoma in Chinese population. PloS One 28, e89111 (2014).
37. Chen, D. et al. ANRIL inhibits p15 (INK4b) through the TGFb1 signaling pathway in human esophageal squamous cell carcinoma. Cell Immunol. 289, 91-96 (2014).
38. Zhang, Z. et al. Stemness and inducing differentiation of small cell lung cancer NCI-H446 cells. Cell Death Dis. 16, e633 (2013).